Ann Dermatol.  2010 Aug;22(3):319-322. 10.5021/ad.2010.22.3.319.

A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus

Affiliations
  • 1Department of Dermatology, Eulji Medical Center, College of Medicine, Eulji University, Seoul, Korea. ssjmdderma@eulji.ac.kr
  • 2Department of Pathology, Eulji Medical Center, College of Medicine, Eulji University, Seoul, Korea.

Abstract

Tubular apocrine adenoma (TAA) is a very rare sweat gland tumor. TAA and syringocystadenoma papilliferum (SCAP) rarely develop together in a nevus sebaceus (NS). Herein, we report on a 40-year-old Korean woman with TAA associated with SCAP that developed in a NS located on the scalp.

Keyword

Nevus sebaceus; Syringocystadenoma papilliferum; Tubular apocrine adenoma

MeSH Terms

Adenoma
Adult
Female
Humans
Nevus
Scalp
Sweat Glands

Figure

  • Fig. 1 A solitary, 2.5×2.5 cm well-circumscribed, erosive, erythematous lobulated nodule on the scalp.

  • Fig. 2 Syringocystadenoma papilliferum in the upper portion of the lesion and tubular apocrine adenoma in the lower portion (H&E, ×12.5).

  • Fig. 3 Findings of the upper part of the lesion. (A) Cystic and irregularly dilated tubular structures with deep invagination (H&E, ×200). (B) The lumina are lined by 2 layers of epithelial cells embedded in a fibroblastic stroma with a plentiful plasma cell infiltration (H&E, ×400).

  • Fig. 4 Findings of the lower part of the lesion. (A) Variable sized tubular structures are seen (H&E, ×100). (B) Two layers of cells with evidence of decapitation secretion of the luminal cells are seen (H&E, ×400).

  • Fig. 5 (A) Only focally positive staining results in the syringocystadenoma papilliferum (SCAP) lesion (GCDFP-15, ×100). (B) Strong positive staining results in the tubular apocrine adenoma (TAA) lesion (GCDFP-15, ×200).


Cited by  3 articles

Syringocystadenoma Papilliferum of the Back Combined with a Tubular Apocrine Adenoma
Hyun Joo Lee, Eujin Cho, Min Ho Kim, Sang Hyun Cho, Jeong Deuk Lee
Ann Dermatol. 2011;23(Suppl 2):S151-S154.    doi: 10.5021/ad.2011.23.S2.S151.

Syringocystadenoma Papilliferum in Co-existence with Tubular Apocrine Adenoma on the Calf
Jung Hee Yoon, Hyo Hyun Ahn, Young Chul Kye, Soo Hong Seo
Ann Dermatol. 2011;23(Suppl 2):S175-S178.    doi: 10.5021/ad.2011.23.S2.S175.

Syringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature
Kyoung Geun Lee, Won Choi, Joon Soo Lim, Hyung Jin Hahn, Ki Bum Myung, Seung Hyun Cheong
Ann Dermatol. 2019;31(5):559-562.    doi: 10.5021/ad.2019.31.5.559.


Reference

1. Landry M, Winkelmann RK. An unusual tubular apocrine adenoma. Arch Dermatol. 1972. 105:869–879.
Article
2. Fischer TL. Tubular apocrine adenoma. Arch Dermatol. 1973. 107:137.
Article
3. Umbert P, Winkelmann RK. Tubular apocrine adenoma. J Cutan Pathol. 1976. 3:75–87.
Article
4. Toribio J, Zulaica A, Peteiro C. Tubular apocrine adenoma. J Cutan Pathol. 1987. 14:114–117.
Article
5. Ansai S, Watanabe S, Aso K. A case of tubular apocrine adenoma with syringocystadenoma papilliferum. J Cutan Pathol. 1989. 16:230–236.
Article
6. Ishiko A, Shimizu H, Inamoto N, Nakmura K. Is tubular apocrine adenoma a distinct clinical entity? Am J Dermatopathol. 1993. 15:482–487.
Article
7. Aktepe F, Demir Y, Dilek FH. Tubular apocrine adenoma in association with syringocystadenoma papilliferum. Dermatol Online J. 2003. 9:7.
Article
8. Ahn BK, Park YK, Kim YC. A case of tubular apocrine adenoma with syringocystadenoma papilliferum arising in nevus sebaceus. J Dermatol. 2004. 31:508–510.
Article
9. Lee CK, Jang KT, Cho YS. Tubular apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal. J Laryngol Otol. 2005. 119:1004–1006.
Article
10. Yamane N, Kato N, Yanagi T, Osawa R. Naevus sebaceus on the female breast accompanied with a tubular apocrine adenoma and a syringocystadenoma papilliferum. Br J Dermatol. 2007. 156:1397–1399.
Article
11. Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol. 2000. 42:263–268.
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr